INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
118 hedge funds and large institutions have $246M invested in Insys Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less call options, than puts
Call options by funds: $4.05M | Put options by funds: $5.78M
Holders
118
Holding in Top 10
–
Calls
$4.05M
Puts
$5.78M
Top Buyers
| 1 | +$8.02M | |
| 2 | +$1.46M | |
| 3 | +$1.27M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$1M |
| 5 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
+$879K |
Top Sellers
| 1 | -$4.76M | |
| 2 | -$4.57M | |
| 3 | -$2.86M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$2.73M |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
-$2.43M |